Dementia and Movement Disorder Treatment Market, Global Outlook and Forecast 2024-2031

Report ID: 1140457 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Dementia and Movement Disorder Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Dementia and Movement Disorder Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Dementia and Movement Disorder Treatment Overall Market Size
    2.1 Global Dementia and Movement Disorder Treatment Market Size: 2021 VS 2028
    2.2 Global Dementia and Movement Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Dementia and Movement Disorder Treatment Players in Global Market
    3.2 Top Global Dementia and Movement Disorder Treatment Companies Ranked by Revenue
    3.3 Global Dementia and Movement Disorder Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Dementia and Movement Disorder Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Dementia and Movement Disorder Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Dementia and Movement Disorder Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Dementia and Movement Disorder Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Dementia and Movement Disorder Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Dementia and Movement Disorder Treatment Market Size Markets, 2021 & 2028
        4.1.2 MAO Inhibitors (Monoamine Oxidase)
        4.1.3 AChE Inhibitors (Acetylcholinesterase)
        4.1.4 Glutamate Inhibitors
    4.2 By Type - Global Dementia and Movement Disorder Treatment Revenue & Forecasts
        4.2.1 By Type - Global Dementia and Movement Disorder Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Dementia and Movement Disorder Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Dementia and Movement Disorder Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Dementia and Movement Disorder Treatment Revenue & Forecasts
        5.2.1 By Application - Global Dementia and Movement Disorder Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Dementia and Movement Disorder Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Dementia and Movement Disorder Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Dementia and Movement Disorder Treatment Revenue & Forecasts
        6.2.1 By Region - Global Dementia and Movement Disorder Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Dementia and Movement Disorder Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Dementia and Movement Disorder Treatment Revenue, 2017-2028
        6.3.2 US Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.3.3 Canada Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.3.4 Mexico Dementia and Movement Disorder Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Dementia and Movement Disorder Treatment Revenue, 2017-2028
        6.4.2 Germany Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.4.3 France Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.4.4 U.K. Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.4.5 Italy Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.4.6 Russia Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.4.8 Benelux Dementia and Movement Disorder Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Dementia and Movement Disorder Treatment Revenue, 2017-2028
        6.5.2 China Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.5.3 Japan Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.5.4 South Korea Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.5.6 India Dementia and Movement Disorder Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Dementia and Movement Disorder Treatment Revenue, 2017-2028
        6.6.2 Brazil Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.6.3 Argentina Dementia and Movement Disorder Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Dementia and Movement Disorder Treatment Revenue, 2017-2028
        6.7.2 Turkey Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.7.3 Israel Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Dementia and Movement Disorder Treatment Market Size, 2017-2028
        6.7.5 UAE Dementia and Movement Disorder Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Dementia and Movement Disorder Treatment Major Product Offerings
        7.1.4 Pfizer Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Dementia and Movement Disorder Treatment Major Product Offerings
        7.2.4 Novartis Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Roche
        7.3.1 Roche Corporate Summary
        7.3.2 Roche Business Overview
        7.3.3 Roche Dementia and Movement Disorder Treatment Major Product Offerings
        7.3.4 Roche Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.3.5 Roche Key News
    7.4 Teva
        7.4.1 Teva Corporate Summary
        7.4.2 Teva Business Overview
        7.4.3 Teva Dementia and Movement Disorder Treatment Major Product Offerings
        7.4.4 Teva Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.4.5 Teva Key News
    7.5 Amgen
        7.5.1 Amgen Corporate Summary
        7.5.2 Amgen Business Overview
        7.5.3 Amgen Dementia and Movement Disorder Treatment Major Product Offerings
        7.5.4 Amgen Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.5.5 Amgen Key News
    7.6 UCB
        7.6.1 UCB Corporate Summary
        7.6.2 UCB Business Overview
        7.6.3 UCB Dementia and Movement Disorder Treatment Major Product Offerings
        7.6.4 UCB Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.6.5 UCB Key News
    7.7 H. Lundbeck
        7.7.1 H. Lundbeck Corporate Summary
        7.7.2 H. Lundbeck Business Overview
        7.7.3 H. Lundbeck Dementia and Movement Disorder Treatment Major Product Offerings
        7.7.4 H. Lundbeck Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.7.5 H. Lundbeck Key News
    7.8 Eli Lilly
        7.8.1 Eli Lilly Corporate Summary
        7.8.2 Eli Lilly Business Overview
        7.8.3 Eli Lilly Dementia and Movement Disorder Treatment Major Product Offerings
        7.8.4 Eli Lilly Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.8.5 Eli Lilly Key News
    7.9 Allergan
        7.9.1 Allergan Corporate Summary
        7.9.2 Allergan Business Overview
        7.9.3 Allergan Dementia and Movement Disorder Treatment Major Product Offerings
        7.9.4 Allergan Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.9.5 Allergan Key News
    7.10 Eisai
        7.10.1 Eisai Corporate Summary
        7.10.2 Eisai Business Overview
        7.10.3 Eisai Dementia and Movement Disorder Treatment Major Product Offerings
        7.10.4 Eisai Dementia and Movement Disorder Treatment Revenue in Global Market (2017-2022)
        7.10.5 Eisai Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Dementia and Movement Disorder Treatment Market Opportunities & Trends in Global Market
    Table 2. Dementia and Movement Disorder Treatment Market Drivers in Global Market
    Table 3. Dementia and Movement Disorder Treatment Market Restraints in Global Market
    Table 4. Key Players of Dementia and Movement Disorder Treatment in Global Market
    Table 5. Top Dementia and Movement Disorder Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Dementia and Movement Disorder Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Dementia and Movement Disorder Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Dementia and Movement Disorder Treatment Product Type
    Table 9. List of Global Tier 1 Dementia and Movement Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Dementia and Movement Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Dementia and Movement Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Dementia and Movement Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Dementia and Movement Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Dementia and Movement Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Dementia and Movement Disorder Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Dementia and Movement Disorder Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Dementia and Movement Disorder Treatment Product Offerings
    Table 32. Pfizer Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Dementia and Movement Disorder Treatment Product Offerings
    Table 35. Novartis Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Roche Corporate Summary
    Table 37. Roche Dementia and Movement Disorder Treatment Product Offerings
    Table 38. Roche Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Teva Corporate Summary
    Table 40. Teva Dementia and Movement Disorder Treatment Product Offerings
    Table 41. Teva Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Amgen Corporate Summary
    Table 43. Amgen Dementia and Movement Disorder Treatment Product Offerings
    Table 44. Amgen Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. UCB Corporate Summary
    Table 46. UCB Dementia and Movement Disorder Treatment Product Offerings
    Table 47. UCB Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. H. Lundbeck Corporate Summary
    Table 49. H. Lundbeck Dementia and Movement Disorder Treatment Product Offerings
    Table 50. H. Lundbeck Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Eli Lilly Corporate Summary
    Table 52. Eli Lilly Dementia and Movement Disorder Treatment Product Offerings
    Table 53. Eli Lilly Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Allergan Corporate Summary
    Table 55. Allergan Dementia and Movement Disorder Treatment Product Offerings
    Table 56. Allergan Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Eisai Corporate Summary
    Table 58. Eisai Dementia and Movement Disorder Treatment Product Offerings
    Table 59. Eisai Dementia and Movement Disorder Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Dementia and Movement Disorder Treatment Segment by Type in 2021
    Figure 2. Dementia and Movement Disorder Treatment Segment by Application in 2021
    Figure 3. Global Dementia and Movement Disorder Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Dementia and Movement Disorder Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Dementia and Movement Disorder Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Dementia and Movement Disorder Treatment Revenue in 2021
    Figure 8. By Type - Global Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 12. US Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 24. China Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Dementia and Movement Disorder Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Roche Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Teva Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Amgen Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. UCB Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. H. Lundbeck Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Eli Lilly Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Allergan Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Eisai Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Dementia and Movement Disorder Treatment Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dementia and Movement Disorder Treatment Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dementia and Movement Disorder Treatment Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports